eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
6.44
+0.24 (3.96%)
At close: Sep 18, 2026, 4:00 PM EDT
6.44
+0.01 (0.08%)
After-hours: Sep 18, 2026, 6:34 PM EDT
eXoZymes Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.65 | 3.04 | 9.72 | 0.07 | 0.56 | 0.55 |
Cash & Short-Term Investments | 5.65 | 3.04 | 9.72 | 0.07 | 0.56 | 0.55 |
Cash Growth | -19.08% | -68.73% | 14508.25% | -88.09% | 1.97% | - |
Other Receivables | 0.22 | 0.52 | 0.74 | 0.88 | 0.81 | 0.47 |
Receivables | 0.22 | 0.52 | 0.74 | 0.88 | 0.81 | 0.47 |
Prepaid Expenses | 0.3 | 0.38 | 0.36 | 0.26 | 0.1 | 0.03 |
Total Current Assets | 6.17 | 3.94 | 10.82 | 1.21 | 1.47 | 1.05 |
Property, Plant & Equipment | 1.71 | 1.93 | 2.21 | 2.34 | 1.22 | 1.3 |
Other Long-Term Assets | 0.11 | 0.11 | - | - | - | - |
Total Assets | 7.98 | 5.97 | 13.03 | 3.56 | 2.69 | 2.35 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.27 | 1.24 | 0.92 | 0.7 | 0.39 | 0.27 |
Accrued Expenses | - | 0.01 | 0.18 | 0.45 | 0.04 | - |
Short-Term Debt | - | - | - | 1 | - | - |
Current Portion of Leases | 0.34 | 0.33 | 0.23 | 0.22 | 0.15 | 0.13 |
Current Income Taxes Payable | - | - | - | 0.04 | 0.06 | - |
Total Current Liabilities | 1.62 | 1.57 | 1.33 | 2.42 | 0.63 | 0.4 |
Long-Term Leases | 0.74 | 0.92 | 1.16 | 1.39 | 0.46 | 0.59 |
Long-Term Unearned Revenue | 0.07 | 0.09 | 0.12 | 0.14 | 0.21 | 0.16 |
Total Liabilities | 4.33 | 2.57 | 2.61 | 3.94 | 1.31 | 1.15 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 30.01 | 24.5 | 22.37 | 5.7 | 5.42 | 3.85 |
Retained Earnings | -26.35 | -21.1 | -11.95 | -6.08 | -4.05 | -2.65 |
Shareholders' Equity | 3.65 | 3.4 | 10.42 | -0.38 | 1.37 | 1.2 |
Total Liabilities & Equity | 7.98 | 5.97 | 13.03 | 3.56 | 2.69 | 2.35 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.09 | 1.24 | 1.39 | 2.61 | 0.61 | 0.72 |
Net Cash (Debt) | 4.57 | 1.8 | 8.33 | -2.55 | -0.05 | -0.17 |
Net Cash Growth | -18.31% | -78.44% | - | - | - | - |
Net Cash Per Share | 0.54 | 0.21 | 1.27 | -0.41 | -0.01 | -0.03 |
Filing Date Shares Outstanding | 9.28 | 8.48 | 8.37 | 6.25 | 6.25 | 5.18 |
Total Common Shares Outstanding | 9.28 | 8.41 | 8.37 | 6.25 | 6.25 | 5.18 |
Working Capital | 4.55 | 2.37 | 9.49 | -1.2 | 0.83 | 0.65 |
Book Value Per Share | 0.39 | 0.40 | 1.25 | -0.06 | 0.22 | 0.23 |
Tangible Book Value | 3.65 | 3.4 | 10.42 | -0.38 | 1.37 | 1.2 |
Tangible Book Value Per Share | 0.39 | 0.40 | 1.25 | -0.06 | 0.22 | 0.23 |
Machinery | 1.51 | 1.45 | 1.33 | 0.94 | 0.81 | 0.63 |
Leasehold Improvements | 0.33 | 0.33 | 0.28 | 0.28 | 0.07 | 0.07 |